AHA Scientific Sessions 2025 Abstract
Healthcare Resource Utilization and Costs Before and After Evolocumab Initiation Among Patients With Atherosclerotic Cardiovascular Disease: A Real-World Administrative Claims Analysis
Study in peopleInterventions
The paper
Amgen (United States); Complete HEOR Solutions
AHA Scientific Sessions 2025 Abstract, 3 Nov 2025
Presented at AHA Scientific Sessions 2025, abstract 4365637


